Huminsulin R 100IU Cartridge contains human insulin at a concentration of 100 international units per milliliter, formulated for subcutaneous administration to manage blood glucose levels in patients with diabetes mellitus. This rapid-acting insulin analog mimics endogenous insulin, facilitating glucose uptake by peripheral tissues and inhibiting hepatic glucose production, thereby aiding in the control of hyperglycemia. Huminsulin R is indicated for the treatment of type 1 diabetes mellitus, type 2 diabetes mellitus when diet, exercise, and oral hypoglycemic agents alone do not provide adequate glycemic control, and for diabetic ketoacidosis management. The cartridge is designed for use with compatible insulin delivery devices, ensuring accurate dosing and ease of administration. Onset of action typically occurs within 30 minutes, with a peak effect between 2 to 4 hours and a duration of action up to 6 hours, allowing for flexible dosing schedules tailored to individual patient needs. Proper storage between 2°C and 8°C is essential to maintain insulin potency. Patients should be monitored regularly for blood glucose levels to adjust dosing accordingly and to minimize the risk of hypoglycemia. Huminsulin R should be used under medical supervision with consideration of patient-specific factors including concurrent medications and comorbidities.